Robert Arch, SVP Corporate Development at Immunophotonics, Inc. will be attending the BIO CEO & Investor Conference which will be held on February 10 -11, 2025 in New York at the Marriott Marquis.  This event is among the largest investor conferences focused on established and emerging publicly traded and select private biotech companies.

This conference presents an excellent opportunity to discuss our existing data, including encouraging clinical results from over 100 cancer patients treated with IP-001, and upcoming key milestones with investors and other attendees of the event.